Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 26, 2020 07:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Reports Fourth Quarter and Full-Year 2019 Financial Results

SAINT LAURENT, Quebec, March 26, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx") today reported financial results for the fourth quarter...
March 23, 2020 08:00 ET | Source: IntelGenx Technologies Corp.

INTELGENX TO REPORT FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS ON MARCH 26; CONFERENCE CALL TO FOLLOW ON MARCH 27

SAINT LAURENT, Quebec, March 23, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today announced that it will release its fourth...
February 11, 2020 10:14 ET | Source: IntelGenx Technologies Corp.

IntelGenx Completes C$8.2 Million Equity Offering

SAINT LAURENT, Quebec, Feb. 11, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce that it has closed its offering...
January 27, 2020 17:12 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Pricing of Equity Offering

SAINT LAURENT, Quebec, Jan. 27, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) announced today the pricing of an agency offering...
January 15, 2020 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Receives Health Canada Authorization to Proceed with New Amendment for Montelukast VersaFilm® Phase 2a Trial

- Ongoing BUENA Trial to Continue at Increased Daily Dose - SAINT LAURENT, Quebec, Jan. 15, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in...
January 13, 2020 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Provides Commercial Update on its Two Lead VersaFilm® Product Candidates, Cannabis-Infused Oral Film and RIZAPORT®

SAINT LAURENT, Quebec, Jan. 13, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leader in pharmaceutical films, today provided a commercial update on its two lead...
January 09, 2020 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Enters Animal Health Market by Signing Feasibility Agreement for VetaFilm™ Platform

SAINT LAURENT, Quebec, Jan. 09, 2020 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”) a leader in pharmaceutical films, today announced that it has entered into a...
December 19, 2019 16:30 ET | Source: IntelGenx Technologies Corp.

IntelGenx Files Preliminary Short Form Prospectus in Connection With a Proposed Offering of Units

SAINT LAURENT, Quebec, Dec. 19, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) is pleased to announce that it has filed a preliminary...
December 06, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx Announces Issuance of Shares in Payment of Interest on Outstanding Debentures

SAINT LAURENT, Quebec, Dec. 06, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSXV: IGX) (OTCQX: IGXT) (the “Company” or “IntelGenx”) announces that it intends to issue 415,178 common...
December 03, 2019 08:00 ET | Source: IntelGenx Technologies Corp.

IntelGenx to Present at the First Annual BioTuesdays Pre-JPM Virtual Conference

SAINT LAURENT, Quebec, Dec. 03, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX-V:IGX)(OTCQX:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that...